Kathleen Dass is a Rheumatology/Immunology physician affiliated with Beaumont Health. OpenAlex indexes 30 publications with 605 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
24601 Coolidge Hwy
Oak Park, MI 482371449
Telephone
248-546-9100Registry record last updated 21 Jun 2017.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202516 payments$12,151openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year202512 payments$11,372openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202547 payments$11,284openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
76.3%Corticosteroid29.6%Trelegy Ellipta47%Fluticasone Propionate27%Breztri Aerosphere14%Arnuity Ellipta7%Breo Ellipta3%Dulera3%Part D<11 patientsLeukotriene Receptor Antagonist15.5%Montelukast Sodium100%Part D≥158 patients+ 7 more classes in this area
Dermatology
9.7%Interleukin-4 Receptor alpha Antagonist7.4%Dupixent Syringe73%Dupixent Pen27%Part D<11 patientsCorticosteroid2.3%Methylprednisolone59%Triamcinolone Acetonide41%Part D≥31 patientsMetabolism & gastrointestinal
8%H2 blocker5.6%Famotidine100%Part D≥70 patientsCorticosteroid1.6%Prednisone100%Part D≥26 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- M311 AN UNUSUAL PRESENTATION OF METAL HYPERSENSITIVITY SYMPTOM RECURRENCE DURING OMALIZUMAB TREATMENT SUCCESSFULLY TREATED WITH DUPILUMAB
Annals of Allergy Asthma & Immunology
2021 - Work Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in Athletes
The Journal of Allergy and Clinical Immunology In Practice
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Goldstein, MD
Beaumont Health
Pamela Marcovitz, MD
Beaumont Health
Donald Brabbins
Beaumont Health
Phillip Kraft, MD
Beaumont Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”